Liana Isa Rosenthal, M.D., Ph.D.
Ataxia, Dystonia, Essential Tremor, Movement Disorders, Neurology, Parkinson's Disease ...read more
Biomarkers for Parkinson's disease; Parkinson''s disease related cognitive impairment ...read more
Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital.
Dr. Rosenthal is the director of the Parkinson’s Disease Research Center’s clinical research, specifically the longitudinal and brain donation studies, which seek to improve our understanding of disease progression and the psychiatric and cognitive aspects of Parkinson's disease.
As the co-investigator of an NIH-funded study to identify biomarkers for Parkinson's disease and Parkinson's disease-related cognitive impairment, Dr. Rosenthal supervises all day-to-day operations of clinical research, including patient recruitment and enrollment and clinical assessments of study participants.
Parkinson''s disease
MARK-PD study: Biomarkers for Parkinson's disease (PD) and PD related cognitive impairment.
- Improve diagnosis and treatment of Parkinson's disease
- Improve diagnosis and treatment of people with cognitive changes due to Parkinson's disease
What is Ataxia?
Parkinson's Disease Biomarkers Program with Dr. Liana Rosenthal
Conversations That Matter: New Facts About The Brain - MS, ALS & Parkinson’s Disease
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.